STOCK TITAN
  1. Home
  2. Sec-filings
  3. RVMD
  4. [Form 4] Revolution Medicines, Inc. Insider Trading Activity

[Form 4] Revolution Medicines, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Revolution Medicines, Inc. Chief Financial Officer Anders Jack reported an open-market sale of 2,722 shares of common stock at an average price of $156.1192 per share. The sale was executed under a pre-arranged Rule 10b5-1 instruction letter to cover tax withholding on vested RSUs, and Jack now holds 123,269 shares, including 51,388 RSUs and 479 shares acquired through the employee stock purchase plan.

Positive

  • None.

Negative

  • None.
Insider Anders Jack
Role Chief Financial Officer
Sold 2,722 shs ($425K)
Type Security Shares Price Value
Sale Common Stock 2,722 $156.1192 $425K
Holdings After Transaction: Common Stock — 123,269 shares (Direct, null)
Footnotes (1)
  1. Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8251. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 51,388 RSUs. Includes 479 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.
Shares sold 2,722 shares Open-market sale of common stock
Average sale price $156.1192 per share Weighted average across multiple trades
Shares owned after sale 123,269 shares Total common stock beneficially owned post-transaction
Restricted stock units included 51,388 RSUs Portion of post-transaction holdings
ESPP shares included 479 shares Acquired under Employee Stock Purchase Plan on May 31, 2026
Rule 10b5-1 regulatory
"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
restricted stock units ("RSUs") financial
"to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Employee Stock Purchase Plan financial
"Includes 479 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Anders Jack
(Last)(First)(Middle)
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
(Street)
REDWOOD CITY CALIFORNIA 94063
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Revolution Medicines, Inc. [ RVMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/16/2026S(1)2,722D$156.1192(2)123,269(3)(4)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
2. This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8251. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. Includes 51,388 RSUs.
4. Includes 479 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.
/s/ Jack Anders06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did RVMD CFO Anders Jack report in this Form 4 filing?

RVMD’s CFO Anders Jack reported selling 2,722 shares of common stock in an open-market transaction at an average price of $156.1192 per share. The filing also details his remaining equity stake after this sale.

Why did the RVMD CFO sell 2,722 shares according to the Form 4?

The 2,722-share sale was made under a Rule 10b5-1 instruction letter to satisfy tax withholding obligations tied to vesting restricted stock units. This indicates the transaction was pre-arranged and primarily driven by tax requirements, not discretionary trading.

How many RVMD shares does the CFO hold after this reported sale?

After the reported sale, RVMD CFO Anders Jack beneficially owns 123,269 shares of common stock. This total includes 51,388 restricted stock units and 479 shares previously acquired through the company’s Employee Stock Purchase Plan.

What price did the RVMD CFO receive for the sold shares?

The reported weighted average sale price was $156.1192 per share, based on multiple trades executed between $156.1105 and $156.8251. The CFO has undertaken to provide full trade details, including share counts and prices, upon request.

Was the RVMD CFO’s sale under a Rule 10b5-1 trading plan?

Yes. The Form 4 states the sale followed a Rule 10b5-1 instruction letter adopted on May 31, 2023. This arrangement pre-scheduled sales to address tax withholding on restricted stock units vesting after July 15, 2023.